Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia

Blood

Volumn 88, Issue 11, 1996, Pages 4259-4264

  Sarfati, Marika ^a   Chevret, Sylvie ^b   Chastang, Claude ^b   Biron, Guy ^b   Stryckmans, Pierre ^b   Delespesse, Guy ^b   Binet, Jacques Louis ^b   Merle Beral, Helene ^b   Bron, Dominique ^b  

^a NOTRE DAME HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD23 ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD LEVEL; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE;

EID: 0029912022     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.11.4259.4259     Document Type: Article

References (31)

1. Delespesse G, Sarfati M, Wu CY, Fournier S, Letellier M: The low-affinity receptor for IgE. Immunol Rev 125:77, 1992
2. Bonnefoy JY, Lecoanet-Henchoz S, Aubry JP, Gauchat JF, Graber P: CD23 and B cell activation. Curr Opin Immunol 7:355, 1995
3. Fujiwara H, Kikutani H, Suematsu S, Naka T, Yoshida K, Tanaka T, Suemura M, Matsumoto N, Kojima S: The absence of IgE antibody-mediated augmentation of immune responses in CD23-deficient mice. Proc Natl Acad Sci USA 91:6835, 1994
4. Liu YJ, Cairns JA, Holder MJ, Abbot SD, Jansen KU, Bonnefoy JY, Gordon J, MacLennan ICM: Recombinant 25-kDa CD23 and interleukin 1α promote the survival of germinal center B cells: Evidence for bifurcation in the development of centrocytes rescued from apoptosis. Eur J Immunol 21:1107, 1991
5. Mossalayi MD, Arock M, Bertho JM, Blanc C, Dalloul AH, Hofstetter H, Sarfati M, Delespesse G, Debré P: Proliferation of early human myeloid precursors induced by interleukin-1 and recombinant soluble CD23. Blood 75:1924, 1990
6. Armant M, Ishihara H, Rubio M, Delespesse G, Sarfati M: Regulation of cytokine production by soluble CD23: Costimulation of interferon γ secretion and triggering of tumor necrosis factor α release. J Exp Med 180:1005, 1994
7. O'Brien S, del Giglio A, Keating M: Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 85:307, 1995
8. Montserrat E, Rozman C: Chronic lymphocytic leukemia: Present status. Ann Oncol 6:219, 1995
9. Fournier S, Delespesse G, Rubio M, Biron G, Sarfati M: CD23 antigen regulation and signaling in chronic lymphocytic leukemia. J Clin Invest 89:1312, 1992
10. Fournier S, Rubio M, Delespesse G, Sarfati M: Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation. Blood 84:1881, 1994
11. Sarfati M, Bron D, Lagneaux L, Fonteyn C, Frost H, Delespesse G: Elevation of IgE-binding factors in serum of patients with B cell-derived chronic lymphocytic leukemia. Blood 71:94, 1988
12. Reinisch W, Willheim M, Hilgarth M, Gasché C, Made R, Szepfalusi S, Steger G, Berger R, Lechner K, Boltz-Nitulescu G, Schwarzmeier JD: Soluble CD23 reliably reflects disease activity in B cell chronic lymphocytic leukemia. J Clin Oncol 12:2146, 1994
13. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternack BS: Clinical staging of chronic lymphocytic leukemia. Blood 46:219, 1975
14. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J, Vaugier G, Potron G, Colona P, Oberling F, Thomas M, Tchernia G, Jacquillat C, Boivin P, Lesty C, Duaull MT, Monconduit M, Belabbes S, Gremy F: A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198, 1981
15. Rozman C, Montserrat E, Rodriguez-Fernandez JM, Ayats R, Vallespi T, Parody R, Rios A, Prados D, Morey M, Gomis F, Alcala A, Gutierrez M, Maldonado J, Gonzalez C, Giralt M, Hernandez-Nieto L, Cabrera A, Fernandez-Ranada JM: Bone marrow histologic pattern - The best single prognostic parameter in chronic lymphocytic leukemia: A multivariate survival analysis of 329 cases. Blood 64:642, 1984
16. Pangalis GA, Roussou PA, Kittas C, Kokkinou S, Fessas P: B-chronic lymphocytic leukemia. Prognostic implication of bone marrow histology in 120 patients experience from a single hematology unit. Cancer 59:767, 1987
17. Geisler C, Ralfkiaer E, Hansen MM, Hou-Jensen K, Larsen SO: The bone marrow histological pattern has independent prognostic value in early stage chronic lymphocytic leukaemia. Br J Haematol 62:47, 1986
18. Juliusson G, Oscier DG, Fitchett M, Ross FM, Phil D, Stockdill G, Mackie MJ, Parker AC, Castoldi GL, Cuneo A, Knuutila S, Elonen E, Gahrton G: Prognostic subgroups in B-CLL chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N Engl J Med 323:720, 1990
19. Montserrat E, Sanchez-Bisono J, Vinolas N, Rozman C: Lymphocyte doubling time in chronic lymphocytic leukaemia: Analysis of its prognostic significance. Br J Haematol 62:567, 1986
20. Molica S, Alberti A: Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia. Cancer 60:2712, 1987
21. Kaplan E, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
22. Peto R, Peto J: Asymptotically efficient rank invariant test procedures (with discussion). J Roy Statist Soc A135:185, 1972
23. Cox DR: Regression models and life tables (with discussion). J Roy Stat Soc B34:187, 1972
24. Beguin Y, Lampertz S, De Groote D, Igot D, Malaise M, Fillet G: Soluble CD23 and other receptors (CD4, CD8, CD25, CD71) in serum of patients with chronic lymphocytic leukemia. Leukemia 7:2019, 1993
25. Diegel W, Porzolt F, Schmid M, Hermann F, Lesslaver W, Brockhaus M: High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia. J Clin Invest 89:1690, 1992
26. Geisler CH, Larsen JK, Hansen NE, Hansen MM, Christensen BE, Lund B, Nielsen H, Plesner T, Thorling K, Andersen E, Andersen PK: Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia. Blood 78:1795, 1991
27. Newman RA, Peterson B, Davey FR, Brabyn C, Collins H, Brunetto VL, Duggan DB, Weiss RB, Royston I, Millard FE, Miller AA, Bloomfield CD: Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: A cancer and leukemia group B study. Blood 82:1239, 1993
28. Montserrat E, Rozman C: Chronic lymphocytic leukaemia: Prognostic factors and natural history [Review]. Baillieres Clin Haematol 6:849, 1993
29. French Cooperative Group on Chronic Lymphocytic Leukemia: Effects of chlorambucil and therapeutic decision in the initial forms of chronic lymphocytic leukemia (stage A): Results of a randomized clinical trial on 612 patients. Blood 75:1414, 1990
30. Dhodapkar M, Tefferi A, Su J, Phyliky RL: Prognostic features and survival in young adults with early/intermediate chronic lymphocytic leukemia (B-CLL): A single institution study. Leukemia 7:1232, 1993
31. Montserrat E, Gomis F, Vallespi T, Rios A, Romero A, Soler J, Alcal A, Morey M, Ferran C, Diaz-Mediavilla J, Flores A, Woessner S, Batlle J, Gonzalez-Aza C, Rovira M, Reverter JC, Rozman C: Presenting features and prognosis of chronic lymphocytic leukemia in younger adults. Blood 78:1545, 1991